During the recent session, Syros Pharmaceuticals Inc (NASDAQ:SYRS)’s traded shares were 2.42 million, with the beta value of the company hitting 1.42. At the last
In the last trading session, 365.05 million shares of the Syros Pharmaceuticals Inc (NASDAQ:SYRS) were traded, and its beta was 1.47. Most recently the company’s
In the last trading session, 13.6 million shares of the Syros Pharmaceuticals Inc (NASDAQ:SYRS) were traded, and its beta was 1.50. Most recently the company’s
Syros Pharmaceuticals Inc (NASDAQ:SYRS)’s traded shares stood at 6.29 million during the last session, with the company’s beta value hitting 1.42. At the close of
Syros Pharmaceuticals Inc (NASDAQ:SYRS)’s traded shares stood at 16.65 million during the last session, with the company’s beta value hitting 1.39. At the close of
Syros Pharmaceuticals Inc (NASDAQ:SYRS)’s traded shares stood at 38.11 million during the last session, with the company’s beta value hitting 1.60. At the close of
In the last trading session, 0.54 million Syros Pharmaceuticals Inc (NASDAQ:SYRS) shares changed hands as the company’s beta touched 1.65. With the company’s per share
In last trading session, Syros Pharmaceuticals Inc (NASDAQ:SYRS) saw 0.35 million shares changing hands with its beta currently measuring 1.59. Company’s recent per share price
During the last session, Syros Pharmaceuticals Inc (NASDAQ:SYRS)’s traded shares were 0.52 million, with the beta value of the company hitting 1.59. At the end
In the last trading session, 1.36 million shares of the Syros Pharmaceuticals Inc. (NASDAQ:SYRS) were traded, and its beta was 1.62. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
